The NeoCart Clinical Trial was fully enrolled in June 2017 and is no longer enrolling patients. Visit: Histogenics.com
Have you been told you should have, might need or could benefit from microfracture surgery?
If you answered yes to these questions, you may be eligible to participate in a company-sponsored Phase 3 clinical trial for treatment of cartilage injury in a select group of patients with articular cartilage damage in the knee.
The purpose of the company-sponsored study is to evaluate the safety and effectiveness of an investigational cartilage implant called NeoCart®, compared to the current standard of care procedure, microfracture surgery.
Cartilage damage can be caused by athletic activity, traumatic injury, and even daily wear and tear. Symptoms of an injury can include aching, pain, swelling, locking, catching or giving way of the knee. Only your doctor can determine if your symptoms are due to cartilage injury.
Learn more about how cartilage injury can negatively impact your daily life and activity.
Caution: New Biologic. Limited by Federal law to investigational use only and is not available for sale.